Phos­pho­enolpyru­vic acid cyclo­hexy­lam­mo­ni­um salt CAS 10526-80-4

• Iden­ti­fi­ca­tion
• Prop­er­ties
• Safe­ty Data
• Spec­i­fi­ca­tions & Oth­er Information
• Links
• Quick Inquiry

Iden­ti­fi­ca­tion

CAS Number

10526-80-4

Name

Phos­pho­enolpyru­vic acid cyclo­hexy­lam­mo­ni­um salt

Syn­onyms

10526-80-4 [RN]
2-(Phosphonooxy)acrylic acid – cyclo­hexa­namine (1:1) [ACD/IUPAC Name]
2-(Phosphonooxy)acrylsäure -cyclo­hexa­namin (1:1) [Ger­man] [ACD/IUPAC Name]
234-084-7 [EINECS]
2-Propenoic acid, 2-(phosphonooxy)-, com­pd. with cyclo­hexa­namine (1:1) [ACD/​Index Name]
Acide 2-(phosphonooxy)acrylique – cyclo­hexa­namine (1:1) [French] [ACD/IUPAC Name]
Magen­­ta-GlcA [Trade name]
MFCD00036375 [MDL num­ber]
[10526-80-4] [RN]
2-(Phosphonooxy)-2-propenoic acid mono­cy­clo­hexy­lam­mo­ni­um salt
2-(Phosphonooxy)acrylic acid, com­pound with cyclo­hexy­lamine (1:1)
2-(phosphonooxy)prop-2-enoic acid
2-(phosphonooxy)prop-2-enoic acid ; cyclo­hexa­namine
2-Propenoic acid, 2-(phosphonooxy)-, com­pd. with cyclohexanamine(1:1)
2-Propenoic acid, 2-phos­pho­noxy-, mono­cy­clo­hexy­lam­mo­ni­um salt
35556-70-8 [RN]
95%
98%
Cyclo­hexa­namine 2-(phosphonooxy)acrylate
cyclohexanamine;2-phosphonooxyprop-2-enoic acid
Cyclo­hexy­lamine [Wiki]
cyclo­hexy­lam­mo­ni­um salt
cyclo­hexy­laza­ni­um and 2-phos­pho­nooxyprop-2-enoate
GS-6359
mono­cy­clo­hexy­lam­mo­ni­um salt
P-6100
PEP ? CHX
PEP MCHA salt
PEP-CHA
PHOS­PHO(ENOL)PYRU­VATE MONO(CYCLO­HEXY­LAM­MO­NI­UM) SALT
PHOS­PHO(ENOL)PYRU­VATE­MONO(CYCLO­HEXY­LAM­MO­NI­UM)SALT
Phospho(enol)pyruvic acid cyclo­hexy­lam­mo­ni­um salt
Phos­pho­enolpyru­vate, mono­cy­clo­hexy­lam­mo­ni­um salt
Phos­pho­enolpyru­vic acid [Wiki]
Phos­pho­enolpyru­vic acid cyclo­hexy­lam­mo­ni­um salt
phos­pho­enolpyru­vic acid mono(cyclohexylammonium) salt
Phos­pho­enolpyru­vic Acid Mono­cy­clo­hexy­lam­mo­ni­um Salt
Phos­pho­enolpyru­vic acid, cyclo­hexy­lam­mo­ni­um salt
Phos­pho­enolpyru­vic acid, mono­cy­clo­hexy­lam­mo­ni­um salt
Phos­pho­enolpyru­vic acid ; mono­cy­clo­hexy­lam­mo­ni­um salt
phosphoenolpyruvicacidmono(cyclohexylammonium)salt
SS-0876

SMILES

C=C(C(=O)O)OP(=O)(O)O.C1CCC(CC1)N

Std­InChI

InChI=1S/C6H13N.C3H5O6P/c7-6-4-2-1-3-5-6;1-2(3(4)5)9-10(6,7)8/h6H,1-5,7H2 ;1H2,(H,4,5)(H2,6,7,8)

Std­InChIKey

VHFC­NZD­H­­PABZJO-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C₉H₁₈NO₆P

Mol­e­c­u­lar Weight

267.216

EINECS

234-084-7

MDL Number

MFCD00036375

Prop­er­ties

Appear­ance

White Pow­der

Safe­ty Data

Sym­bol

Sig­nal Word

Warn­ing

WGK Germany

3

MSDS Download

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Phos­pho­enolpyru­vic acid cyclo­hexy­lam­mo­ni­um salt CAS 10526-80-4

Iden­ti­fi­ca­tion Methods

HNMR

Puri­ty

98% min

Water

≤0.5%

Shelf Life

1 year

Stor­age

Store at 2~8 ℃, Sealed and away from light.

Known Appli­ca­tion

Phos­pho­enolpyru­vate mono­cy­lo­hexy­lamine salt (PEP mono­cy­lo­hexy­lamine salt) is an impor­tant organophos­pho­rus com­pound, pri­mar­i­ly used in the fields of bio­chem­istry and phar­ma­ceu­ti­cal research with the fol­low­ing applications :

Sub­strate in Enzyme Reac­tions : Phos­pho­enolpyru­vate (PEP) is a key inter­me­di­ate in the gly­col­y­sis path­way. The mono­cy­lo­hexy­lamine salt form of PEP can be used in vit­ro to study sub­strate behav­ior in enzyme reac­tions, espe­cial­ly in research involv­ing gly­col­y­sis or ener­gy metabolism.

Phos­pho­enolpyru­vate Car­boxyk­i­nase (PEPCK) Stud­ies : PEP is a crit­i­cal sub­strate in reac­tions cat­alyzed by PEPCK, a key enzyme in the glu­co­neo­ge­n­e­sis path­way. Study­ing this process is essen­tial for under­stand­ing metab­o­lism, dia­betes, and oth­er meta­bol­ic disorders.

ATP Syn­the­sis : In vit­ro ATP syn­the­sis exper­i­ments often use PEP to pro­vide phos­phate groups, gen­er­at­ing ATP through reac­tions with ADP. This is high­ly valu­able for research on cel­lu­lar ener­gy metabolism.

Drug Devel­op­ment and Bio­med­ical Research : PEP mono­cy­lo­hexy­lamine salt may be used in the devel­op­ment of metab­o­lism-relat­ed drugs, par­tic­u­lar­ly for research tar­get­ing meta­bol­ic path­ways asso­ci­at­ed with dis­eases such as can­cer or diabetes.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Lim­it­ed (http://​www​.cam​ing​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.